GOLDENWELL BIOTECH, INC. (GWLL)
2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|
| Sales | - | - | - | 139 |
| Cost of revenues | - | - | - | 69 |
| Service revenue | 37,500 | - | - | - |
| Gross profit | 37,500 | - | - | 70 |
| General and administrative | 40,620 | 32,277 | 23,065 | 49,990 |
| Total operating expenses | 40,620 | 32,277 | 23,065 | 49,990 |
| Operation income | -3,120 | -32,277 | -23,065 | -49,920 |
| Interest expense | 2,100 | 2,100 | - | - |
| Loss before income taxes | - | -34,377 | - | - |
| Net loss | -5,220 | -34,377 | -23,065 | -49,920 |
| Basic & diluted eps | - | - | - | - |
| Basic & diluted average shares | - | - | - | 96,433,333 |
| Diluted eps | - | - | - | - |
| Weighted average number of shares outstanding - basic and diluted | 96,433,333 | 99,000,000 | - | - |